GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Coral Laboratories Ltd (BOM:524506) » Definitions » Cyclically Adjusted PB Ratio

Coral Laboratories (BOM:524506) Cyclically Adjusted PB Ratio : 1.33 (As of Jul. 12, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Coral Laboratories Cyclically Adjusted PB Ratio?

As of today (2025-07-12), Coral Laboratories's current share price is ₹600.40. Coral Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₹453.02. Coral Laboratories's Cyclically Adjusted PB Ratio for today is 1.33.

The historical rank and industry rank for Coral Laboratories's Cyclically Adjusted PB Ratio or its related term are showing as below:

BOM:524506' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.37   Med: 0.95   Max: 1.99
Current: 1.31

During the past years, Coral Laboratories's highest Cyclically Adjusted PB Ratio was 1.99. The lowest was 0.37. And the median was 0.95.

BOM:524506's Cyclically Adjusted PB Ratio is ranked better than
66.53% of 747 companies
in the Drug Manufacturers industry
Industry Median: 2.03 vs BOM:524506: 1.31

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Coral Laboratories's adjusted book value per share data for the three months ended in Mar. 2025 was ₹563.128. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹453.02 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coral Laboratories Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Coral Laboratories's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coral Laboratories Cyclically Adjusted PB Ratio Chart

Coral Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.09 0.77 0.62 0.91 1.55

Coral Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 - 1.97 - 1.55

Competitive Comparison of Coral Laboratories's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Coral Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coral Laboratories's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Coral Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Coral Laboratories's Cyclically Adjusted PB Ratio falls into.


;
;

Coral Laboratories Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Coral Laboratories's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=600.40/453.02
=1.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coral Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Coral Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=563.128/157.5517*157.5517
=563.128

Current CPI (Mar. 2025) = 157.5517.

Coral Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.000 99.841 0.000
201509 181.037 101.753 280.312
201512 0.000 102.901 0.000
201603 196.415 102.518 301.854
201606 0.000 105.961 0.000
201609 216.029 105.961 321.210
201612 0.000 105.196 0.000
201703 305.507 105.196 457.557
201706 0.000 107.109 0.000
201709 397.354 109.021 574.234
201712 0.000 109.404 0.000
201803 325.597 109.786 467.256
201806 0.000 111.317 0.000
201809 311.067 115.142 425.641
201812 0.000 115.142 0.000
201903 318.415 118.202 424.416
201906 0.000 120.880 0.000
201909 309.714 123.175 396.152
201912 0.000 126.235 0.000
202003 323.736 124.705 409.006
202006 0.000 127.000 0.000
202009 363.588 130.118 440.246
202012 0.000 130.889 0.000
202103 382.433 131.771 457.257
202106 0.000 134.084 0.000
202109 440.132 135.847 510.453
202112 0.000 138.161 0.000
202203 436.757 138.822 495.684
202206 0.000 142.347 0.000
202209 450.343 144.661 490.473
202212 0.000 145.763 0.000
202303 433.244 146.865 464.770
202306 0.000 150.280 0.000
202309 481.510 151.492 500.770
202312 0.000 152.924 0.000
202403 496.772 153.035 511.435
202406 0.000 155.789 0.000
202409 569.682 157.882 568.489
202412 0.000 158.323 0.000
202503 563.128 157.552 563.128

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coral Laboratories  (BOM:524506) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Coral Laboratories Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Coral Laboratories's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Coral Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Lal Bahadur Shastri Road, No. 3-B, Patanwala Industrial Estate, Opposite Shreyas Cinema, Ghatkopar (West), Mumbai, MH, IND, 400086
Coral Laboratories Ltd is engaged in the pharmaceutical business. The company is involved in the formulation of medicines. The company's dosage form includes tablets, capsules, liquid orals, b-lactam, dry syrup, meter dose inhalers, injectables, drops, sprays, special kits, and others. Its geographical segments include Ethiopia, India, and the Rest of the world.

Coral Laboratories Headlines

No Headlines